FDA: Wockhardt plant staff barred inspectors, tossed testing data

In a newly disclosed warning letter, the FDA said Wockhardt's quality-control staff wouldn't allow agency representatives to inspect an aseptic filling area at its troubled Waluj, India, plant. Company employees also appeared to have misled inspectors by discarding data on product testing, the letter said. Report

Suggested Articles

Turns out Procter & Gamble didn’t want Pfizer’s consumer health unit after all. But it did want Merck KGaA’s.

Private equity firm, in exclusive talks with Sanofi, says it'll invest to pump up Zentiva into an "independent European generics leader."

With suitor Takeda circling Shire, the Dublin-based target has pulled off a deal of its own.